Category: Patent Legislation

  •     By Donald Zuhn — The Senate Judiciary Committee has placed the Senate patent reform bill (S. 515) on the agenda for the Committee's March 19th Executive Business Meeting.  The meeting, which begins at 10:00 am (Eastern), will be webcast.  The meeting agenda and a webcast link can be found at the Committee's website. On…

  •     By Donald Zuhn — BIO Seeks Improvements to Patent Reform Legislation Following Tuesday's hearing on patent reform, the Biotechnology Industry Organization (BIO) issued a press release urging the Senate Judiciary Committee to make improvements to its new patent reform bill (S. 515).  The organization's written testimony, which was submitted to the Committee on Tuesday,…

  •     By Donald Zuhn — For almost two hours this morning, the Senate Judiciary Committee heard testimony regarding its efforts to reform U.S. patent law.  Not surprisingly, much of the discussion at the hearing focused on Section 4 of the Senate patent reform bill (S. 515), which concerns damages.  The damages provision of S. 515…

  •     By Donald Zuhn — On Tuesday, Senator Arlen Spector (R-PA) (at right), the ranking member of the Senate Judiciary Committee, sent a letter to Committee Chairman Patrick Leahy (D-VT), requesting that the Senate patent reform bill (S. 515) "not be placed on the Executive Business Agenda until late May, after the Court of Appeals…

  •     By Donald Zuhn — During yesterday's press conference announcing the introduction of new patent reform legislation in both the Senate and House, Senate Judiciary Committee Chairman Patrick Leahy (D-VT) noted that the Senate Judiciary Committee would be holding a hearing on patent reform next week.  The hearing, entitled "Patent Reform in the 111th Congress: …

  •     By Donald Zuhn — In a joint press conference held earlier today, leaders from both the Senate and House announced the introduction of new patent reform legislation.  Appearing at the conference were Senator Patrick Leahy (D-VT), the Chairman of the Senate Judiciary Committee, Senator Orrin Hatch (R-UT), Representative John Conyers (D-MI), the Chairman of…

  •     By Kevin E. Noonan — The Biotechnology Industry Organization (BIO) held one of its periodic meetings with the press today for a wide-ranging discussion of its policy goals and agendas for the new Congress and administration.  A panel of BIO officials, headed by President and CEO James Greenwood, answered questions from more than a…

  •     By Donald Zuhn — Earlier today, the Manufacturing Alliance on Patent Policy (MAPP) let us know, through its media relations firm, that "well sourced rumors" have pegged Monday, March 2nd as the day on which the first of perhaps three patent reform bills will be introduced in the 111th Congress.  The 110th Congress saw…

  •     By Kevin E. Noonan — Rick Weiss gets it when it comes to the value of patents.  "Patents assure an inventor a period of time, generally 20 years, to exclude others from using the invention, in return for a full explication of that invention by the patent holder," he says.  "The assurance that competitors…

  •     By Donald Zuhn — Last month, the Manufacturing Alliance on Patent Policy (MAPP) released a report that indicates that the apportionment of damages provisions found in prior Senate (S. 1145) and House (H.R. 1908) patent reform bills would have adverse effects on the U.S. economy.  In particular, the report concludes that an apportionment system…